Archives
Polyethylenimine Linear (PEI, MW 40,000): High-Efficiency...
Polyethylenimine Linear (PEI, MW 40,000): High-Efficiency DNA Transfection Reagent for In Vitro Studies
Executive Summary: Polyethylenimine Linear (PEI), MW 40,000, is a positively charged polymer optimized for DNA transfection in in vitro studies. Its efficacy is rooted in its ability to condense DNA into positively charged complexes, facilitating endocytosis-mediated uptake in mammalian cells (Roach 2024). PEI offers transfection efficiencies of 60–80% in compatible cell lines such as HEK-293, CHO-K1, HepG2, and HeLa under serum-containing conditions (internal source). The reagent is scalable from 96-well plate formats to 100-liter bioreactor systems. For long-term integrity, it should be stored at -20°C, with working solutions stable at 4°C. APExBIO supplies this product as the K1029 kit, supporting a broad range of molecular biology and protein production workflows (APExBIO product page).
Biological Rationale
Efficient delivery of nucleic acids into mammalian cells is essential for gene function studies and recombinant protein production. Polyethylenimine Linear (PEI), MW 40,000, serves as a cationic polymer that complexes with negatively charged DNA, overcoming the electrostatic barrier of the cell membrane. This property is exploited in transient gene expression protocols and functional genomics. PEI's compatibility with serum-containing media and its ability to maintain high transfection efficiency across multiple cell lines (e.g., HEK-293, CHO-K1, HepG2, and HeLa) make it a versatile tool in molecular biology research (internal source). The product's linear structure is associated with reduced cytotoxicity compared to branched variants, expanding its utility in sensitive cell systems (Roach 2024).
Mechanism of Action of Polyethylenimine Linear (PEI), MW 40,000
PEI is a polycationic polymer with a high density of primary and secondary amines. When mixed with plasmid DNA, PEI condenses the DNA into nanoscale, positively charged complexes via electrostatic interactions. These PEI/DNA complexes bind to anionic proteoglycans and glycoproteins on the cell membrane, promoting cellular uptake primarily through clathrin-mediated endocytosis (Roach 2024). Once internalized, the 'proton sponge' effect of PEI buffers endosomal acidification, facilitating endosomal escape and subsequent release of DNA into the cytosol. This ensures efficient delivery to the nucleus for transcription and subsequent protein expression. The linear architecture of PEI MW 40,000 optimizes the balance between DNA binding strength and release, enhancing transfection efficiency while minimizing cytotoxicity (internal source: extends neuroepigenetic applications).
Evidence & Benchmarks
- Transfection efficiencies of 60–80% are routinely achieved in HEK-293, CHO-K1, HepG2, and HeLa cells using Polyethylenimine Linear (PEI), MW 40,000 in serum-containing conditions (internal source).
- PEI-mediated DNA condensation yields complexes with hydrodynamic diameters of 100–200 nm, optimal for endocytosis (Roach 2024, Table 2).
- Transient gene expression with PEI supports applications ranging from small-scale (96-well) to large-scale (100-liter bioreactor) transfections (APExBIO product page).
- Linear PEI demonstrates lower cytotoxicity compared to branched forms at equivalent mass ratios in multiple mammalian cell lines (Roach 2024, MTT assay).
Applications, Limits & Misconceptions
Polyethylenimine Linear (PEI), MW 40,000, is widely used for:
- Transient gene expression for recombinant protein production.
- Functional gene studies in mammalian cell lines, including HEK-293, HEK293T, CHO-K1, HepG2, and HeLa.
- DNA and mRNA delivery for in vitro screening and functional genomics.
- Scale-adaptable workflows, from high-throughput microplate formats to large-scale bioreactor transfections.
For further exploration of advanced applications such as mRNA nanoparticle delivery, see this article, which expands upon the current discussion by examining PEI's versatility beyond DNA.
Common Pitfalls or Misconceptions
- PEI MW 40,000 is not suitable for in vivo gene delivery due to systemic toxicity and lack of tissue targeting.
- High PEI:DNA ratios can increase cytotoxicity without proportionally improving transfection efficiency.
- Not all cell types are equally permissive; primary and suspension cells may require protocol optimization.
- Serum compatibility does not guarantee absence of cytotoxicity; optimization is needed for sensitive systems.
- Repeated freeze-thaw cycles reduce reagent activity; aliquoting is recommended for storage at -20°C.
For a critical review of how PEI MW 40,000 benchmarks against other reagents and addresses misconceptions, this article provides comparative data, while the present article updates these findings with new evidence from recent thesis research.
Workflow Integration & Parameters
Polyethylenimine Linear (PEI), MW 40,000 (K1029, APExBIO) is supplied as a 2.5 mg/mL solution in 4 mL or 8 mL volumes. For optimal transfection, DNA:PEI mass ratios between 1:2 and 1:3 (w/w) are commonly used, with complex formation in physiological buffers (e.g., 150 mM NaCl or HEPES, pH 7.4) at room temperature for 15–20 minutes prior to cell application. PEI/DNA complexes are added directly to cells in serum-containing media, with typical incubation times of 4–6 hours before media replacement. The reagent is compatible with high-throughput and large-scale workflows, including bioreactors up to 100 liters for industrial protein production. For long-term storage, maintain at -20°C; working aliquots can be kept at 4°C for up to several weeks to minimize freeze-thaw cycles. For further insights into optimization and advanced integration in neuroepigenetics, see this article, which this article extends by providing broader workflow context.
Conclusion & Outlook
Polyethylenimine Linear (PEI), MW 40,000, remains a cornerstone DNA transfection reagent for in vitro studies, owing to its high efficiency, serum compatibility, and scalability from research to industrial applications. Ongoing development is expanding its scope to novel payloads (e.g., mRNA) and cell models, as highlighted in recent academic and product literature. APExBIO's K1029 formulation is validated for reproducible results across a spectrum of cell biology and molecular biology protocols. Researchers should adhere to optimized protocols and storage guidelines to maximize performance and minimize cytotoxicity. For additional reference, see the official product page and recent peer-reviewed benchmarks.